Physician profile
Michael Lynn Smith
NPI 1629606165
$2,540.83
in general payments reported to CMS, 2019-2025
14 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $521 · 2023: $573 · 2024: $722 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,020.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $862.35 | 2022-2025 | Spaceoar Vue System - 10ml, Lithovue, Spaceoar System |
| Jazz Pharmaceuticals INC. | $493.05 | 2022-2023 | Xywav |
| Avadel Cns Pharmaceuticals, LLC | $329.49 | 2024-2025 | Lumryz |
| Procept Biorobotics Corporation | $190.00 | 2025 | |
| Calyxo, INC. | $173.24 | 2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $148.00 | 2022-2024 | Xtandi |
| Idorsia Pharmaceuticals US INC | $113.63 | 2023 | Quviviq |
| Abbvie INC. | $77.83 | 2025 | |
| Coloplast Corp | $54.20 | 2025 | |
| Becton, Dickinson and Company | $27.54 | 2025 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $24.10 | 2023 | Pylarify |
| Pfizer INC. | $17.46 | 2025 | |
| Merck Sharp & Dohme LLC | $16.35 | 2024 | Bridion |
| Teleflex LLC | $13.59 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.